This enzyme has been shown to interact with DNMTs and shape a carcinogenic methylation profile, and it was found upregulated in many malignancies including GC, predicting worse prognosis of patients and modulating the expression of E-cadherin in vitro [107,113,114]. The gene discussed is CDH1; the disease is gastric cancer.